
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $6B | $7.7B | $8B | $6.1B | $6B | |
Revenue Growth (YoY) | -11.46% | 27.45% | 4.6% | -23.83% | -1.23% | |
Cost of Revenues | $4.9B | $6.1B | $6.5B | $5.2B | $5.2B | |
Gross Profit | $1.1B | $1.6B | $1.5B | $906M | $866M | |
Gross Profit Margin | 18.28% | 20.65% | 19.27% | 14.83% | 14.35% | |
R&D Expenses | $135M | $135M | $125M | $115M | $121M | |
Selling, General & Admin | $775M | $739M | $711M | $689M | $671M | |
Other Inc / (Exp) | $188M | $570M | $1M | $62M | -$33M | |
Operating Expenses | $865M | $841M | $788M | $804M | $793M | |
Operating Income | $235M | $743M | $758M | $102M | $73M | |
Net Interest Expenses | $86M | $67M | $62M | $65M | $79M | |
EBT. Incl. Unusual Items | $337M | $1.2B | $697M | $99M | -$39M | |
Earnings of Discontinued Ops. | $775M | $49M | $12M | $118M | -$27M | |
Income Tax Expense | $46M | $191M | $186M | $64M | $61M | |
Net Income to Company | $291M | $1.1B | $511M | $35M | -$100M | |
Minority Interest in Earnings | -$32M | -$59M | -$63M | -$52M | -$62M | |
Net Income to Common Excl Extra Items | $1B | $1B | $460M | $101M | -$189M | |
Basic EPS (Cont. Ops) | $4.69 | $4.77 | $2.29 | $0.57 | -$1.10 | |
Diluted EPS (Cont. Ops) | $4.66 | $4.72 | $2.27 | $0.57 | -$1.10 | |
Weighted Average Basic Share | $220.6M | $219.2M | $201M | $177.4M | $172.1M | |
Weighted Average Diluted Share | $221.9M | $221.4M | $203M | $177.4M | $172.1M | |
EBITDA | $706M | $1.6B | $1B | $442M | $329M | |
EBIT | $423M | $1.3B | $759M | $164M | $40M | |
Revenue (Reported) | $6B | $7.7B | $8B | $6.1B | $6B | |
Operating Income (Reported) | $235M | $743M | $758M | $102M | $73M | |
Operating Income (Adjusted) | $423M | $1.3B | $759M | $164M | $40M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.8B | $2.2B | $1.6B | $1.5B | $1.4B | |
Revenue Growth (YoY) | 15.32% | 19.33% | -26.73% | -8.47% | -4.08% | |
Cost of Revenues | $1.4B | $1.7B | $1.3B | $1.3B | $1.2B | |
Gross Profit | $392M | $515M | $269M | $201M | $201M | |
Gross Profit Margin | 21.34% | 23.5% | 16.75% | 13.67% | 14.26% | |
R&D Expenses | $38M | $34M | $30M | $31M | $32M | |
Selling, General & Admin | $207M | $190M | $188M | $176M | $166M | |
Other Inc / (Exp) | $2M | $13M | $19M | -$61M | $36M | |
Operating Expenses | $242M | $232M | $215M | $157M | $191M | |
Operating Income | $150M | $283M | $54M | $44M | $10M | |
Net Interest Expenses | $19M | $14M | $18M | $19M | $19M | |
EBT. Incl. Unusual Items | $133M | $282M | $55M | -$36M | $27M | |
Earnings of Discontinued Ops. | $1M | $18M | $122M | -$7M | -$1M | |
Income Tax Expense | $34M | $60M | $11M | -$20M | $15M | |
Net Income to Company | $99M | $222M | $44M | -$16M | $12M | |
Minority Interest in Earnings | -$17M | -$17M | -$13M | -$14M | -$16M | |
Net Income to Common Excl Extra Items | $83M | $223M | $153M | -$37M | -$5M | |
Basic EPS (Cont. Ops) | $0.38 | $1.05 | $0.84 | -$0.22 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.37 | $1.04 | $0.83 | -$0.22 | -$0.03 | |
Weighted Average Basic Share | $220.4M | $212.7M | $182.7M | $171.8M | $172.4M | |
Weighted Average Diluted Share | $222.6M | $215.4M | $184.4M | $171.8M | $172.4M | |
EBITDA | $226M | $363M | $142M | $52M | $115M | |
EBIT | $152M | $296M | $73M | -$17M | $46M | |
Revenue (Reported) | $1.8B | $2.2B | $1.6B | $1.5B | $1.4B | |
Operating Income (Reported) | $150M | $283M | $54M | $44M | $10M | |
Operating Income (Adjusted) | $152M | $296M | $73M | -$17M | $46M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6.3B | $8.4B | $7.4B | $6B | $6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5.1B | $6.6B | $6.1B | $5.1B | $5.1B | |
Gross Profit | $1.2B | $1.8B | $1.3B | $838M | $866M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $137M | $139M | $121M | $116M | $122M | |
Selling, General & Admin | $783M | $778M | $709M | $677M | $661M | |
Other Inc / (Exp) | $291M | $583M | $7M | -$18M | $63M | |
Operating Expenses | $867M | $895M | $771M | $746M | $826M | |
Operating Income | $328M | $911M | $529M | $92M | $40M | |
Net Interest Expenses | $87M | $62M | $66M | $66M | $79M | |
EBT. Incl. Unusual Items | $532M | $1.4B | $470M | $8M | $24M | |
Earnings of Discontinued Ops. | -$1M | $38M | $116M | -$11M | -$21M | |
Income Tax Expense | $73M | $226M | $137M | $33M | $96M | |
Net Income to Company | $459M | $1.2B | $333M | -$25M | -$72M | |
Minority Interest in Earnings | -$46M | -$59M | -$59M | -$53M | -$64M | |
Net Income to Common Excl Extra Items | $412M | $1.2B | $390M | -$89M | -$157M | |
Basic EPS (Cont. Ops) | $1.88 | $5.47 | $1.98 | -$0.52 | -$0.91 | |
Diluted EPS (Cont. Ops) | $1.85 | $5.41 | $1.95 | -$0.52 | -$0.91 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $909M | $1.8B | $819M | $352M | $392M | |
EBIT | $619M | $1.5B | $536M | $74M | $103M | |
Revenue (Reported) | $6.3B | $8.4B | $7.4B | $6B | $6B | |
Operating Income (Reported) | $328M | $911M | $529M | $92M | $40M | |
Operating Income (Adjusted) | $619M | $1.5B | $536M | $74M | $103M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.8B | $2.2B | $1.6B | $1.5B | $1.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4B | $1.7B | $1.3B | $1.3B | $1.2B | |
Gross Profit | $392M | $515M | $269M | $201M | $201M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $38M | $34M | $30M | $31M | $32M | |
Selling, General & Admin | $207M | $190M | $188M | $176M | $166M | |
Other Inc / (Exp) | $2M | $13M | $19M | -$61M | $36M | |
Operating Expenses | $242M | $232M | $215M | $157M | $191M | |
Operating Income | $150M | $283M | $54M | $44M | $10M | |
Net Interest Expenses | $19M | $14M | $18M | $19M | $19M | |
EBT. Incl. Unusual Items | $133M | $282M | $55M | -$36M | $27M | |
Earnings of Discontinued Ops. | $1M | $18M | $122M | -$7M | -$1M | |
Income Tax Expense | $34M | $60M | $11M | -$20M | $15M | |
Net Income to Company | $99M | $222M | $44M | -$16M | $12M | |
Minority Interest in Earnings | -$17M | -$17M | -$13M | -$14M | -$16M | |
Net Income to Common Excl Extra Items | $83M | $223M | $153M | -$37M | -$5M | |
Basic EPS (Cont. Ops) | $0.38 | $1.05 | $0.84 | -$0.22 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.37 | $1.04 | $0.83 | -$0.22 | -$0.03 | |
Weighted Average Basic Share | $220.4M | $212.7M | $182.7M | $171.8M | $172.4M | |
Weighted Average Diluted Share | $222.6M | $215.4M | $184.4M | $171.8M | $172.4M | |
EBITDA | $226M | $363M | $142M | $52M | $115M | |
EBIT | $152M | $296M | $73M | -$17M | $46M | |
Revenue (Reported) | $1.8B | $2.2B | $1.6B | $1.5B | $1.4B | |
Operating Income (Reported) | $150M | $283M | $54M | $44M | $10M | |
Operating Income (Adjusted) | $152M | $296M | $73M | -$17M | $46M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1B | $654M | $540M | $340M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $910M | $1B | $834M | $753M | $725M | |
Inventory | $848M | $1B | $995M | $867M | $917M | |
Prepaid Expenses | -- | -- | -- | $92M | $114M | |
Other Current Assets | $217M | $155M | $190M | $62M | $29M | |
Total Current Assets | $3.6B | $3.9B | $3.1B | $2.3B | $2.1B | |
Property Plant And Equipment | $3B | $2.8B | $2.8B | $2.7B | $2.9B | |
Long-Term Investments | $373M | $470M | $425M | $438M | $346M | |
Goodwill | $533M | $650M | $641M | $644M | $633M | |
Other Intangibles | $453M | $469M | $425M | $387M | $344M | |
Other Long-Term Assets | $548M | $871M | $686M | $611M | $722M | |
Total Assets | $8.7B | $9.4B | $8.2B | $7.2B | $7.1B | |
Accounts Payable | $876M | $1.1B | $961M | $719M | $770M | |
Accrued Expenses | $329M | $329M | $317M | $279M | $299M | |
Current Portion Of Long-Term Debt | $593M | $12M | $66M | $12M | $325M | |
Current Portion Of Capital Lease Obligations | $52M | $49M | $51M | $46M | $54M | |
Other Current Liabilities | -- | $163M | $194M | -- | -- | |
Total Current Liabilities | $2B | $2.1B | $1.7B | $1.2B | $1.6B | |
Long-Term Debt | $1.5B | $1.5B | $1.7B | $1.7B | $1.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5B | $4.8B | $4.4B | $3.8B | $4B | |
Common Stock | $3M | $3M | $3M | $3M | $3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $3.5B | $4.4B | $3.6B | $3.3B | $3B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $154M | $181M | $216M | $227M | $204M | |
Total Equity | $3.7B | $4.6B | $3.8B | $3.5B | $3.2B | |
Total Liabilities and Equity | $8.7B | $9.4B | $8.2B | $7.2B | $7.1B | |
Cash and Short Terms | $1.6B | $1B | $654M | $540M | $340M | |
Total Debt | $2.1B | $1.6B | $1.7B | $1.7B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $673M | $807M | $615M | $552M | $334M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1B | $1.3B | $887M | $837M | $797M | |
Inventory | $1B | $1.4B | $1B | $896M | $1B | |
Prepaid Expenses | -- | -- | -- | -- | $95M | |
Other Current Assets | $228M | $156M | $150M | $158M | $30M | |
Total Current Assets | $2.9B | $4B | $2.7B | $2.4B | $2.3B | |
Property Plant And Equipment | $2.9B | $2.9B | $2.7B | $3B | $2.9B | |
Long-Term Investments | $411M | $485M | $441M | $457M | $317M | |
Goodwill | $739M | $650M | $642M | $640M | $637M | |
Other Intangibles | $422M | $461M | $415M | $378M | $334M | |
Other Long-Term Assets | $571M | $673M | $696M | $563M | $722M | |
Total Assets | $8.3B | $9.4B | $7.8B | $7.6B | $7.2B | |
Accounts Payable | $953M | $1.3B | $857M | $745M | $738M | |
Accrued Expenses | $505M | $732M | $381M | $386M | $460M | |
Current Portion Of Long-Term Debt | $57M | $21M | $11M | $396M | $284M | |
Current Portion Of Capital Lease Obligations | $49M | $50M | $48M | $52M | $58M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.6B | $2.1B | $1.3B | $1.6B | $1.5B | |
Long-Term Debt | $1.5B | $1.5B | $1.5B | $1.7B | $1.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.6B | $4.9B | $3.8B | $4.2B | $4.1B | |
Common Stock | $3M | $3M | $3M | $3M | $3M | |
Other Common Equity Adj | -- | -- | -$1.1B | -$1.3B | -$1.2B | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $171M | $197M | $227M | $242M | $220M | |
Total Equity | $3.7B | $4.5B | $4B | $3.4B | $3.2B | |
Total Liabilities and Equity | $8.3B | $9.4B | $7.8B | $7.6B | $7.2B | |
Cash and Short Terms | $673M | $807M | $615M | $552M | $334M | |
Total Debt | $1.6B | $1.6B | $1.5B | $2.1B | $2B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $291M | $1.1B | $511M | $35M | -$100M | |
Depreciation & Amoritzation | $283M | $278M | $281M | $278M | $289M | |
Stock-Based Compensation | $27M | $30M | $29M | $28M | $30M | |
Change in Accounts Receivable | $100M | -$646M | $479M | $103M | $7M | |
Change in Inventories | $145M | -$342M | -$6M | $125M | -$77M | |
Cash From Operations | $253M | $952M | $914M | $209M | $263M | |
Capital Expenditures | $249M | $326M | $272M | $230M | $184M | |
Cash Acquisitions | $1.6B | -$202M | -- | $544M | $46M | |
Cash From Investing | $1.5B | -$524M | -$279M | $305M | -$126M | |
Dividends Paid (Ex Special Dividend) | -$144M | -$159M | -$171M | -$169M | -$174M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $447M | $219M | -- | $349M | |
Long-Term Debt Repaid | -$365M | -$990M | -$12M | -$62M | -$400M | |
Repurchase of Common Stock | -$96M | -$200M | -$1B | -$349M | -$4M | |
Other Financing Activities | -$45M | -$70M | -$17M | -$35M | -$92M | |
Cash From Financing | -$655M | -$977M | -$994M | -$620M | -$326M | |
Beginning Cash (CF) | $525M | $1.6B | $1B | $654M | $540M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.1B | -$549M | -$359M | -$106M | -$189M | |
Ending Cash (CF) | $1.6B | $1B | $654M | $540M | $340M | |
Levered Free Cash Flow | $4M | $626M | $642M | -$21M | $79M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $99M | $222M | $44M | -$16M | $12M | |
Depreciation & Amoritzation | $74M | $67M | $69M | $69M | $69M | |
Stock-Based Compensation | $9M | $10M | $9M | $9M | $9M | |
Change in Accounts Receivable | -$117M | -$119M | -$23M | -$87M | -$65M | |
Change in Inventories | -$156M | -$158M | -$50M | -$38M | -$101M | |
Cash From Operations | -$17M | $85M | -$154M | -$65M | -$74M | |
Capital Expenditures | $98M | $64M | $46M | $42M | $36M | |
Cash Acquisitions | -$225M | -- | $541M | $12M | $41M | |
Cash From Investing | -$323M | -$65M | $489M | -$30M | $6M | |
Dividends Paid (Ex Special Dividend) | -$37M | -$46M | -$44M | -$44M | -$44M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $9M | -- | -- | $191M | $427M | |
Long-Term Debt Repaid | -$548M | -$3M | -$224M | -$31M | -$319M | |
Repurchase of Common Stock | -- | -$203M | -$97M | -$1M | -- | |
Other Financing Activities | -- | -- | -$5M | -$2M | -$1M | |
Cash From Financing | -$579M | -$252M | -$379M | $108M | $60M | |
Beginning Cash (CF) | $1.6B | $1B | $654M | $540M | $340M | |
Foreign Exchange Rate Adjustment | -$1M | -$2M | $5M | -$1M | $2M | |
Additions / Reductions | -$919M | -$232M | -$44M | $13M | -$8M | |
Ending Cash (CF) | $673M | $807M | $615M | $552M | $334M | |
Levered Free Cash Flow | -$115M | $21M | -$200M | -$107M | -$110M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $459M | $1.2B | $333M | -$25M | -$72M | |
Depreciation & Amoritzation | $290M | $271M | $283M | $278M | $289M | |
Stock-Based Compensation | $29M | $31M | $28M | $28M | $30M | |
Change in Accounts Receivable | $17M | -$648M | $575M | $39M | $29M | |
Change in Inventories | $81M | -$344M | $102M | $137M | -$140M | |
Cash From Operations | $311M | $1.1B | $675M | $298M | $254M | |
Capital Expenditures | $286M | $292M | $254M | $226M | $178M | |
Cash Acquisitions | -$164M | $23M | $541M | $15M | $75M | |
Cash From Investing | -$371M | -$266M | $275M | -$214M | -$90M | |
Dividends Paid (Ex Special Dividend) | -$144M | -$168M | -$169M | -$169M | -$174M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $9M | -- | -- | -- | $585M | |
Long-Term Debt Repaid | -$723M | -$445M | -$233M | $131M | -$688M | |
Repurchase of Common Stock | -- | -$403M | -$899M | -$253M | -$3M | |
Other Financing Activities | -- | -- | -- | -$32M | -$91M | |
Cash From Financing | -$880M | -$650M | -$1.1B | -$133M | -$374M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$940M | $138M | -$171M | -$49M | -$210M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $25M | $762M | $421M | $72M | $76M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $99M | $222M | $44M | -$16M | $12M | |
Depreciation & Amoritzation | $74M | $67M | $69M | $69M | $69M | |
Stock-Based Compensation | $9M | $10M | $9M | $9M | $9M | |
Change in Accounts Receivable | -$117M | -$119M | -$23M | -$87M | -$65M | |
Change in Inventories | -$156M | -$158M | -$50M | -$38M | -$101M | |
Cash From Operations | -$17M | $85M | -$154M | -$65M | -$74M | |
Capital Expenditures | $98M | $64M | $46M | $42M | $36M | |
Cash Acquisitions | -$225M | -- | $541M | $12M | $41M | |
Cash From Investing | -$323M | -$65M | $489M | -$30M | $6M | |
Dividends Paid (Ex Special Dividend) | -$37M | -$46M | -$44M | -$44M | -$44M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $9M | -- | -- | $191M | $427M | |
Long-Term Debt Repaid | -$548M | -$3M | -$224M | -$31M | -$319M | |
Repurchase of Common Stock | -- | -$203M | -$97M | -$1M | -- | |
Other Financing Activities | -- | -- | -$5M | -$2M | -$1M | |
Cash From Financing | -$579M | -$252M | -$379M | $108M | $60M | |
Beginning Cash (CF) | $1.6B | $1B | $654M | $540M | $340M | |
Foreign Exchange Rate Adjustment | -$1M | -$2M | $5M | -$1M | $2M | |
Additions / Reductions | -$919M | -$232M | -$44M | $13M | -$8M | |
Ending Cash (CF) | $673M | $807M | $615M | $552M | $334M | |
Levered Free Cash Flow | -$115M | $21M | -$200M | -$107M | -$110M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.